Therapeutic Advances in Rare Disease

SAGE Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Therapeutic Advances in Rare Disease is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
2633-0040
Country
United Kingdom
Languages
english
Access
Open access
Articles in DOAJ
140
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2022-05-25
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

140

Most recent article

last month

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

131

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

14

i10-index

19

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2024-04-04
Added to DOAJ
2022-05-25
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
85%
ORCID iDs in current deposits
82%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918557474706676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine

LCC codes

RC31-1245

Subject areas

  • Genomics and Rare Diseases
  • Genomics and Rare Diseases
  • Lysosomal Storage Disorders Research
  • Lysosomal Storage Disorders Research
  • Mitochondrial Function and Pathology
  • Genetics and Neurodevelopmental Disorders
  • Genetics and Neurodevelopmental Disorders
  • Health Systems, Economic Evaluations, Quality of Life
Show all subjects (50)
  • Health Systems, Economic Evaluations, Quality of Life
  • Mitochondrial Function and Pathology
  • Glycogen Storage Diseases and Myoclonus
  • Glycogen Storage Diseases and Myoclonus
  • Metabolism and Genetic Disorders
  • Metabolism and Genetic Disorders
  • Neurogenetic and Muscular Disorders Research
  • Neurogenetic and Muscular Disorders Research
  • Genetic Neurodegenerative Diseases
  • Genetic Neurodegenerative Diseases
  • Hemophilia Treatment and Research
  • Cellular transport and secretion
  • CRISPR and Genetic Engineering
  • Genomic variations and chromosomal abnormalities
  • Hemophilia Treatment and Research
  • Autoimmune and Inflammatory Disorders Research
  • Genomic variations and chromosomal abnormalities
  • CRISPR and Genetic Engineering
  • Cellular transport and secretion
  • Autoimmune and Inflammatory Disorders Research
  • Biomedical Ethics and Regulation
  • Hereditary Neurological Disorders
  • Autism Spectrum Disorder Research
  • Vasculitis and related conditions
  • Hereditary Neurological Disorders
  • Autism Spectrum Disorder Research
  • Retinal Development and Disorders
  • Congenital heart defects research
  • Retinal Development and Disorders
  • Cystic Fibrosis Research Advances
  • Vasculitis and related conditions
  • Cystic Fibrosis Research Advances
  • Congenital heart defects research
  • Biomedical Ethics and Regulation
  • Virus-based gene therapy research
  • Renal Diseases and Glomerulopathies
  • Epilepsy research and treatment
  • Connexins and lens biology
  • Renal Diseases and Glomerulopathies
  • Parathyroid Disorders and Treatments
  • Epilepsy research and treatment
  • Virus-based gene therapy research

Keywords (DOAJ)

  • rare diseases
  • genetics
  • clinical medicine
  • clinical and molecular aspects of rare diseases
  • medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: